Global Intranasal Corticosteroids Market Insights, Forecast to 2029

Publisher Name :
Date: 03-Aug-2023
No. of pages: 94
Inquire Before Buying

Intranasal corticosteroids are the only potent and effective drugs which are used to treat various nasal complications such as nasal-polyps, nasal-rhinitis and chronic sinusitis.

Market Analysis and Insights: Global Intranasal Corticosteroids Market

The global Intranasal Corticosteroids market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Intranasal Corticosteroids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Intranasal Corticosteroids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Intranasal Corticosteroids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Intranasal Corticosteroids include GlaxoSmithKline, Merck, Sanofi, SUMITOMO, Teva, Johnson & Johnson and AstraZeneca, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Intranasal Corticosteroids market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Intranasal Corticosteroids, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Intranasal Corticosteroids, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intranasal Corticosteroids revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Intranasal Corticosteroids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Intranasal Corticosteroids revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including GlaxoSmithKline, Merck, Sanofi, SUMITOMO, Teva, Johnson & Johnson and AstraZeneca, etc.

By Company

- GlaxoSmithKline

- Merck

- Sanofi

- SUMITOMO

- Teva

- Johnson & Johnson

- AstraZeneca

Segment by Type

- Prescribed Drugs

- OTC Drugs

Segment by Application

- Hospital Pharmacies

- Online Pharnacies

- Retail Pharmacies

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Intranasal Corticosteroids in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intranasal Corticosteroids companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intranasal Corticosteroids revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Intranasal Corticosteroids Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intranasal Corticosteroids Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Prescribed Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Intranasal Corticosteroids Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Online Pharnacies
1.3.4 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intranasal Corticosteroids Market Perspective (2018-2029)
2.2 Global Intranasal Corticosteroids Growth Trends by Region
2.2.1 Intranasal Corticosteroids Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Intranasal Corticosteroids Historic Market Size by Region (2018-2023)
2.2.3 Intranasal Corticosteroids Forecasted Market Size by Region (2024-2029)
2.3 Intranasal Corticosteroids Market Dynamics
2.3.1 Intranasal Corticosteroids Industry Trends
2.3.2 Intranasal Corticosteroids Market Drivers
2.3.3 Intranasal Corticosteroids Market Challenges
2.3.4 Intranasal Corticosteroids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Intranasal Corticosteroids by Players
3.1.1 Global Intranasal Corticosteroids Revenue by Players (2018-2023)
3.1.2 Global Intranasal Corticosteroids Revenue Market Share by Players (2018-2023)
3.2 Global Intranasal Corticosteroids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Intranasal Corticosteroids, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Intranasal Corticosteroids Market Concentration Ratio
3.4.1 Global Intranasal Corticosteroids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intranasal Corticosteroids Revenue in 2022
3.5 Global Key Players of Intranasal Corticosteroids Head office and Area Served
3.6 Global Key Players of Intranasal Corticosteroids, Product and Application
3.7 Global Key Players of Intranasal Corticosteroids, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Intranasal Corticosteroids Breakdown Data by Type
4.1 Global Intranasal Corticosteroids Historic Market Size by Type (2018-2023)
4.2 Global Intranasal Corticosteroids Forecasted Market Size by Type (2024-2029)
5 Intranasal Corticosteroids Breakdown Data by Application
5.1 Global Intranasal Corticosteroids Historic Market Size by Application (2018-2023)
5.2 Global Intranasal Corticosteroids Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Intranasal Corticosteroids Market Size (2018-2029)
6.2 North America Intranasal Corticosteroids Market Size by Type
6.2.1 North America Intranasal Corticosteroids Market Size by Type (2018-2023)
6.2.2 North America Intranasal Corticosteroids Market Size by Type (2024-2029)
6.2.3 North America Intranasal Corticosteroids Market Share by Type (2018-2029)
6.3 North America Intranasal Corticosteroids Market Size by Application
6.3.1 North America Intranasal Corticosteroids Market Size by Application (2018-2023)
6.3.2 North America Intranasal Corticosteroids Market Size by Application (2024-2029)
6.3.3 North America Intranasal Corticosteroids Market Share by Application (2018-2029)
6.4 North America Intranasal Corticosteroids Market Size by Country
6.4.1 North America Intranasal Corticosteroids Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Intranasal Corticosteroids Market Size by Country (2018-2023)
6.4.3 North America Intranasal Corticosteroids Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Intranasal Corticosteroids Market Size (2018-2029)
7.2 Europe Intranasal Corticosteroids Market Size by Type
7.2.1 Europe Intranasal Corticosteroids Market Size by Type (2018-2023)
7.2.2 Europe Intranasal Corticosteroids Market Size by Type (2024-2029)
7.2.3 Europe Intranasal Corticosteroids Market Share by Type (2018-2029)
7.3 Europe Intranasal Corticosteroids Market Size by Application
7.3.1 Europe Intranasal Corticosteroids Market Size by Application (2018-2023)
7.3.2 Europe Intranasal Corticosteroids Market Size by Application (2024-2029)
7.3.3 Europe Intranasal Corticosteroids Market Share by Application (2018-2029)
7.4 Europe Intranasal Corticosteroids Market Size by Country
7.4.1 Europe Intranasal Corticosteroids Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Intranasal Corticosteroids Market Size by Country (2018-2023)
7.4.3 Europe Intranasal Corticosteroids Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Intranasal Corticosteroids Market Size (2018-2029)
8.2 China Intranasal Corticosteroids Market Size by Type
8.2.1 China Intranasal Corticosteroids Market Size by Type (2018-2023)
8.2.2 China Intranasal Corticosteroids Market Size by Type (2024-2029)
8.2.3 China Intranasal Corticosteroids Market Share by Type (2018-2029)
8.3 China Intranasal Corticosteroids Market Size by Application
8.3.1 China Intranasal Corticosteroids Market Size by Application (2018-2023)
8.3.2 China Intranasal Corticosteroids Market Size by Application (2024-2029)
8.3.3 China Intranasal Corticosteroids Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Intranasal Corticosteroids Market Size (2018-2029)
9.2 Asia Intranasal Corticosteroids Market Size by Type
9.2.1 Asia Intranasal Corticosteroids Market Size by Type (2018-2023)
9.2.2 Asia Intranasal Corticosteroids Market Size by Type (2024-2029)
9.2.3 Asia Intranasal Corticosteroids Market Share by Type (2018-2029)
9.3 Asia Intranasal Corticosteroids Market Size by Application
9.3.1 Asia Intranasal Corticosteroids Market Size by Application (2018-2023)
9.3.2 Asia Intranasal Corticosteroids Market Size by Application (2024-2029)
9.3.3 Asia Intranasal Corticosteroids Market Share by Application (2018-2029)
9.4 Asia Intranasal Corticosteroids Market Size by Region
9.4.1 Asia Intranasal Corticosteroids Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Intranasal Corticosteroids Market Size by Region (2018-2023)
9.4.3 Asia Intranasal Corticosteroids Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Type
10.2.1 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Application
10.3.1 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Country
10.4.1 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Intranasal Corticosteroids Introduction
11.1.4 GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2018-2023)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Intranasal Corticosteroids Introduction
11.2.4 Merck Revenue in Intranasal Corticosteroids Business (2018-2023)
11.2.5 Merck Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Intranasal Corticosteroids Introduction
11.3.4 Sanofi Revenue in Intranasal Corticosteroids Business (2018-2023)
11.3.5 Sanofi Recent Developments
11.4 SUMITOMO
11.4.1 SUMITOMO Company Details
11.4.2 SUMITOMO Business Overview
11.4.3 SUMITOMO Intranasal Corticosteroids Introduction
11.4.4 SUMITOMO Revenue in Intranasal Corticosteroids Business (2018-2023)
11.4.5 SUMITOMO Recent Developments
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Intranasal Corticosteroids Introduction
11.5.4 Teva Revenue in Intranasal Corticosteroids Business (2018-2023)
11.5.5 Teva Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Intranasal Corticosteroids Introduction
11.6.4 Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2018-2023)
11.6.5 Johnson & Johnson Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Intranasal Corticosteroids Introduction
11.7.4 AstraZeneca Revenue in Intranasal Corticosteroids Business (2018-2023)
11.7.5 AstraZeneca Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Intranasal Corticosteroids Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Prescribed Drugs
Table 3. Key Players of OTC Drugs
Table 4. Global Intranasal Corticosteroids Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Intranasal Corticosteroids Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Intranasal Corticosteroids Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Intranasal Corticosteroids Market Share by Region (2018-2023)
Table 8. Global Intranasal Corticosteroids Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Intranasal Corticosteroids Market Share by Region (2024-2029)
Table 10. Intranasal Corticosteroids Market Trends
Table 11. Intranasal Corticosteroids Market Drivers
Table 12. Intranasal Corticosteroids Market Challenges
Table 13. Intranasal Corticosteroids Market Restraints
Table 14. Global Intranasal Corticosteroids Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Intranasal Corticosteroids Revenue Share by Players (2018-2023)
Table 16. Global Top Intranasal Corticosteroids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Corticosteroids as of 2022)
Table 17. Global Intranasal Corticosteroids Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Intranasal Corticosteroids Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Intranasal Corticosteroids, Headquarters and Area Served
Table 20. Global Key Players of Intranasal Corticosteroids, Product and Application
Table 21. Global Key Players of Intranasal Corticosteroids, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intranasal Corticosteroids Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Intranasal Corticosteroids Revenue Market Share by Type (2018-2023)
Table 25. Global Intranasal Corticosteroids Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Intranasal Corticosteroids Revenue Market Share by Type (2024-2029)
Table 27. Global Intranasal Corticosteroids Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Intranasal Corticosteroids Revenue Share by Application (2018-2023)
Table 29. Global Intranasal Corticosteroids Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Intranasal Corticosteroids Revenue Share by Application (2024-2029)
Table 31. North America Intranasal Corticosteroids Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Intranasal Corticosteroids Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Intranasal Corticosteroids Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Intranasal Corticosteroids Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Intranasal Corticosteroids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Intranasal Corticosteroids Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Intranasal Corticosteroids Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Intranasal Corticosteroids Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Intranasal Corticosteroids Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Intranasal Corticosteroids Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Intranasal Corticosteroids Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Intranasal Corticosteroids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Intranasal Corticosteroids Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Intranasal Corticosteroids Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Intranasal Corticosteroids Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Intranasal Corticosteroids Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Intranasal Corticosteroids Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Intranasal Corticosteroids Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Intranasal Corticosteroids Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Intranasal Corticosteroids Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Intranasal Corticosteroids Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Intranasal Corticosteroids Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Intranasal Corticosteroids Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Intranasal Corticosteroids Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Intranasal Corticosteroids Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Intranasal Corticosteroids Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size by Country (2024-2029) & (US$ Million)
Table 63. GlaxoSmithKline Company Details
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Intranasal Corticosteroids Product
Table 66. GlaxoSmithKline Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 67. GlaxoSmithKline Recent Developments
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Intranasal Corticosteroids Product
Table 71. Merck Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 72. Merck Recent Developments
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Intranasal Corticosteroids Product
Table 76. Sanofi Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 77. Sanofi Recent Developments
Table 78. SUMITOMO Company Details
Table 79. SUMITOMO Business Overview
Table 80. SUMITOMO Intranasal Corticosteroids Product
Table 81. SUMITOMO Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 82. SUMITOMO Recent Developments
Table 83. Teva Company Details
Table 84. Teva Business Overview
Table 85. Teva Intranasal Corticosteroids Product
Table 86. Teva Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 87. Teva Recent Developments
Table 88. Johnson & Johnson Company Details
Table 89. Johnson & Johnson Business Overview
Table 90. Johnson & Johnson Intranasal Corticosteroids Product
Table 91. Johnson & Johnson Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 92. Johnson & Johnson Recent Developments
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Intranasal Corticosteroids Product
Table 96. AstraZeneca Revenue in Intranasal Corticosteroids Business (2018-2023) & (US$ Million)
Table 97. AstraZeneca Recent Developments
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intranasal Corticosteroids Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Intranasal Corticosteroids Market Share by Type: 2022 VS 2029
Figure 3. Prescribed Drugs Features
Figure 4. OTC Drugs Features
Figure 5. Global Intranasal Corticosteroids Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Intranasal Corticosteroids Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Online Pharnacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Intranasal Corticosteroids Report Years Considered
Figure 11. Global Intranasal Corticosteroids Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Intranasal Corticosteroids Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Intranasal Corticosteroids Market Share by Region: 2022 VS 2029
Figure 14. Global Intranasal Corticosteroids Market Share by Players in 2022
Figure 15. Global Top Intranasal Corticosteroids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Corticosteroids as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Intranasal Corticosteroids Revenue in 2022
Figure 17. North America Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Intranasal Corticosteroids Market Share by Type (2018-2029)
Figure 19. North America Intranasal Corticosteroids Market Share by Application (2018-2029)
Figure 20. North America Intranasal Corticosteroids Market Share by Country (2018-2029)
Figure 21. United States Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Intranasal Corticosteroids Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Intranasal Corticosteroids Market Share by Type (2018-2029)
Figure 25. Europe Intranasal Corticosteroids Market Share by Application (2018-2029)
Figure 26. Europe Intranasal Corticosteroids Market Share by Country (2018-2029)
Figure 27. Germany Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Intranasal Corticosteroids Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Intranasal Corticosteroids Market Share by Type (2018-2029)
Figure 35. China Intranasal Corticosteroids Market Share by Application (2018-2029)
Figure 36. Asia Intranasal Corticosteroids Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Intranasal Corticosteroids Market Share by Type (2018-2029)
Figure 38. Asia Intranasal Corticosteroids Market Share by Application (2018-2029)
Figure 39. Asia Intranasal Corticosteroids Market Share by Region (2018-2029)
Figure 40. Japan Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Intranasal Corticosteroids Market Share by Country (2018-2029)
Figure 50. Brazil Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Intranasal Corticosteroids Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 57. Merck Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 58. Sanofi Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 59. SUMITOMO Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 60. Teva Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 61. Johnson & Johnson Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 62. AstraZeneca Revenue Growth Rate in Intranasal Corticosteroids Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs